UBS AM
HGEN

UBS AM’s HUMANIGEN, INC. HGEN Stock Holding History

UBS AM’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,846
Closed -$92.8K – 2807
2022
Q1 		$92.8K Hold
30,846
– – ﹤0.01% 2744
2021
Q4 		$115K Buy
30,846
+5,482
+22% +$32.1K ﹤0.01% 2812
2021
Q3 		$150K Buy
25,364
+4,017
+19% +$56.4K ﹤0.01% 2709
2021
Q2 		$371K Buy
+21,347
New +$389K ﹤0.01% 2604

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM's HGEN Position: Q2 2022 in Review

UBS AM sold out of HUMANIGEN, INC. (HGEN) in Q2 2022, closing a stake of 30,846 shares — an estimated $92.8K sold.

UBS AM first reported a position in HGEN in Q2 2021 and held it in 4 quarters. The position peaked at $371K in Q2 2021. 65 funds tracked by Wall St. Rank hold HGEN as of Q2 2022.

  • UBS AM reported no remaining HUMANIGEN, INC. position as of Q2 2022 after selling out during the quarter.
  • UBS AM sold 30,846 HUMANIGEN, INC. shares in Q2 2022, an estimated $92.8K.
  • UBS AM first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 4 quarters.
  • UBS AM's HUMANIGEN, INC. position peaked at $371K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2022.

Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.